A multi-centre phase I trial of the PARP inhibitor olaparib in patients with relapsed chronic lymphocytic leukaemia, T-prolymphocytic leukaemia or mantle cell lymphoma

2018-08

Pratt, G

Yap, C

Oldreive, C

Slade, D

Bishop, R

Griffiths, M

Dyer, MJS

Fegan, C

Oscier, D

Pettitt, A

Matutes, E

Devereux, S

Allsup, D

Bloor, A

Hillmen, P

Follows, G

Rule, S

Moss, P

Stankovic, T

Journal Article

2018-08

British Journal of Haematology, 2018, 182 (3), pp. 429 - 433

Publications Repository